Last quarter (Q3 2023), Journey Medical Corp's total revenue was $34.54M, an increase of 114.31% from the same quarter last year. In Q3, Journey Medical Corp's net income was $16.79M. See Journey Medical Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 79.80M	$ 73.67M	$ 63.13M	$ 44.53M	$ 34.92M
Cost of Revenue	$ 74.48M	$ 30.77M	$ -32.08M	$ 14.59M	$ 10.53M
Gross Profit	$ 58.99M	$ 42.89M	$ 7.69M	$ 29.94M	$ 24.39M
Operating Expense	$ 58.35M	$ 70.41M	$ 42.57M	$ 22.09M	$ 19.13M
Operating Income	$ 642.00K	$ -27.52M	$ -34.88M	$ 7.85M	$ 5.26M
Net Non Operating Interest Income Expense	$ -2.12M	$ -2.02M	$ -7.03M	$ -698.00K	$ -255.00K
Other Income Expense	$ -8.57M	$ -2.61M	$ 447.00K	-	-
Pretax Income	$ -12.24M	$ -29.57M	$ -42.36M	$ 7.15M	$ 5.00M
Tax Provision	$ 108.00K	$ 63.00K	$ 1.63M	$ 1.87M	$ 1.38M
Earnings From Equity Interest Net Of Tax	-	-	$ 820.00K	-	-
Net Income Common Stockholders	$ -12.35M	$ -29.75M	$ -43.99M	$ 5.28M	$ 3.63M
Basic EPS	$ -0.73	$ -1.69	$ -4.32	$ 0.32	$ 0.22
Diluted EPS	$ -0.84	$ -1.69	$ -4.32	$ 0.32	$ 0.22
Basic Average Shares	$ 71.76M	$ 17.53M	$ 10.19M	$ 16.44M	$ 16.44M
Diluted Average Shares	$ 74.38M	$ 17.53M	$ 10.19M	$ 16.44M	$ 16.44M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 132.82M	$ 101.19M	$ 10.49M	$ 36.68M	$ 29.66M
Net Income From Continuing And Discontinued Operation	$ -12.35M	$ -29.63M	$ -43.99M	$ 5.28M	$ 3.63M
Normalized Income	$ 16.30M	-	-	$ 5.28M	$ 3.63M
Interest Expense	-	-	-	$ 698.00K	$ 255.00K
EBIT	$ -10.00M	$ -27.55M	$ -35.33M	$ 7.85M	$ 5.26M
EBITDA	$ -5.39M	$ -23.09M	$ -30.19M	$ 9.37M	$ 6.52M

Currency in USD

Journey Medical Corp Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing